Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Mar
5
2021
Watch Your Language: The Perils of Patent Profanity: Consideration of both the U.S. and Europe Finnegan
Mar
4
2021
Issue Preclusion Can Apply to Prior Inter Partes Reexamination Determinations Finnegan
Mar
4
2021
Ahoy There : If License Terms Not Clearly Intended to Be a Condition Precedent, It’s a Covenant McDermott Will & Emery
Mar
4
2021
Collaterally Estopped: Do Not Re-Examine the Same Issues McDermott Will & Emery
Mar
4
2021
Chill: Full Recoupment of Investment Not a Bar to Equitable Intervening Rights McDermott Will & Emery
Mar
3
2021
How Two Recent Court Decisions Show Ownership Can Be Everything and Standing Must Be Taken Into Account Finnegan
Mar
1
2021
Buyer Beware: Supreme Court Ruling in Hologic May Merit Additional Contractual Protections Mintz
Feb
26
2021
Spotlight on Upcoming Oral Arguments - March 2021 Finnegan
Feb
26
2021
RCE Costs Patentee Nearly Two Years of PTA Finnegan
Feb
26
2021
Redemption of Loyalty Points is a Patent-Ineligible Abstract Idea, Federal Circuit Holds Finnegan
Feb
25
2021
The Future of Skinny Labeling in Patent Litigation Will be Reconsidered McDermott Will & Emery
Feb
25
2021
Doesn’t Scan: Skin Cancer Detection Device Just Combination of Familiar Elements McDermott Will & Emery
Feb
25
2021
Impossible; Cloud Storage Patent Claims Invalid for Indefiniteness or Not Infringed McDermott Will & Emery
Feb
24
2021
Podcast Series: Last Month at the Federal Circuit - February 2021 Finnegan
Feb
24
2021
Recoup Your Investment and More – Your Equitable Intervening Rights Are Safe Finnegan
Feb
24
2021
Coming Into Focus: Federal Circuit Reverses PTAB, Finds Independent Claims of Immersion Photography Device Unpatentable as Obvious Finnegan
Feb
23
2021
No Unpatentability in a Successful Motion to Amend Finnegan
Feb
23
2021
Federal Circuit Partially Vacates PTAB Decision in Mixed Victory for Samsung Finnegan
Feb
23
2021
Early RCE Creates Gaps In Patent Term Adjustment Award Foley & Lardner LLP
Feb
22
2021
The Federal Circuit Raises the Enablement Bar for Antibody Patents Polsinelli PC
Feb
18
2021
Old Dawg, New Tricks: Bankruptcy Successor Is Also Inter Partes Re-Exam Successor McDermott Will & Emery
Feb
18
2021
Attempts to Appeal Institution Decision Is SIPCOed McDermott Will & Emery
Feb
18
2021
Patent Extension Requires Board or Court Reversal, Multiple Examiner Actions Not Enough McDermott Will & Emery
Feb
18
2021
Stick to the Fax: Conflicting Statements Made During Prosecution Lead to Indefiniteness McDermott Will & Emery
Feb
18
2021
2G or Not 2G: Patent License Applies to Future Generation Wireless Networks McDermott Will & Emery
Feb
17
2021
Copy Cats II: Nexus of Copying Required to Substantiate Non-Obviousness Mintz
Feb
14
2021
Amgen v. Sanofi – How Wands Factors make Biotech Claims “Magically” Disappear Schwegman, Lundberg & Woessner, P.A.
Feb
11
2021
Eight-Month Delay on Transfer Motion Ruling Is “Egregious,” Warrants Stay McDermott Will & Emery
Feb
11
2021
If You Seek or Browse and Can Find, It’s Publicly Available, but Anticipation Isn’t Obvious and Requires Notice McDermott Will & Emery
Feb
11
2021
REI’s CO-OP Mark Rides to Registration After TTAB Rejects Per Se Descriptiveness Rule Finnegan
Feb
10
2021
Federal Circuit Agrees to Reconsider Ruling in GSK v. Teva Drug Patent Case Sheppard, Mullin, Richter & Hampton LLP
Feb
9
2021
Federal Circuit Says Automated Systems Are Not Abstract when Tied to Improvements Mintz
Feb
5
2021
Cementing Victory by Accepting Defeat: When Can a Patentee’s Infringement Disclaimer Moot an Appeal of an IPR Decision? Sheppard, Mullin, Richter & Hampton LLP
Jan
28
2021
2020 IP Law Year in Review: Patents McDermott Will & Emery
Jan
27
2021
JUST OUT: Federal Court Grants Preliminary Approval of Litigation Settlement Involving Alleged Unauthorized Disclosure of Driver Information Squire Patton Boggs (US) LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters